Pathophysiology of atherosclerotic vascular disease

Disease Management and Health Outcomes

Volumn 2, Issue SUPPL. 1, 1997, Pages 1-8

  Cooke, John P ^a   Bhatnagar, Ritu ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0345527518     PISSN: 11738790     EISSN: None     Source Type: Journal    
DOI: 10.2165/00115677-199700021-00003     Document Type: Article

References (30)

1. Ross R. The pathogenesis of atherosclerosis. N Engl J Med 1986; 314: 488-500
2. Cybulsky MI, Gimbrone Jr MA. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991; 251: 788-91
3. Berliner JA, Navab M, Fogelman AM, et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 1995; 91: 2488-96
4. Parhami F, Morrow AD, Balucan J, et al. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 1997; 17: 680-7
5. Knox JB, Sukhova GK, Whittemore AD, et al. Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic disease. Circulation 1997; 95: 205-12
6. European Working Group on Critical Leg Ischemia: second European consensus document on chronic critical leg ischemia. Circulation 1991; 84 Suppl. 4: IV-1-IV-26
7. Cooke JP, Candipan R. Vascular biology of restenosis: insights for therapeutic strategies. J Intervent Cardiol 1994; 6: 25-35
8. Moncada S, Higgs EA. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 1995; 9: 1319-30
9. Cohen RA. The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease. Prog Cardiovasc Dis 1995; XXXVIII (2): 105-28
10. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88: 4651-85
11. Johnson III G, Tsao PS, Mulloy D, et al. Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion. J Pharmacol Exp Ther 1990; 252: 35-41
12. Bath PMW, Hassall DG, Gladwin A-M, et al. Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arterioscler Thromb 1991; 11: 254-60
13. Tsao PS, Lewis NP, Alpert S, et al. Exposure to shear stress alters endothelial adhesiveness: role of nitric oxide. Circulation 1995; 92: 3513-9
14. Zeiher AM, Fisslthaler B, Schray-Utz B, et al. Nitric oxide modulates expression of monocyte chemoattractant protein-a in cultured human endothelial cells. Circ Res 1995; 76: 980-6
15. Tsao PS, Buitrago R, Chan JR, et al. Fluid flow inhibits endothelial adhesiveness: nitric oxide and transcriptional regulation of VCAM-1. Circulation 1996; 94: 1682-9
16. Tsao PS, Wang BY, Buitrago R, et al. Nitric oxide regulates monocyte chemotactic protein-1. Circulation 1997; 96: 934-40
17. Peng HB, Libby P, Liao JK. Induction and stabilisation of 1 kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J Biol Chem 1995; 270: 14214-9
18. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit nitrogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83: 1774-7
19. Wang BY, Candipan RC, Arjomandi M, et al. Arginine restores NO activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits. J Am Coll Cardiol 1996; 28: 1573-9
20. von der Leyen HE, Gibbons GH, Morishita R, et al. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA 1995; 92: 1137-41
21. Schwarzacher SP, Lim TT, Wang BY, et al. Local intramural delivery of L-arginine enhances nitric oxide generation and inhibits lesion formation after balloon angioplasty. Circulation 1997; 95: 1863-9
22. Cooke JP, Tsao PS. Cytoprotective effects of nitric oxide. Circulation 1993; 88: 2151-4
23. Cooke JP, Andon NA, Girerd XJ, et al. Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta. Circulation 1991; 83: 1057-62
24. Cooke JP, Dzau VJ. Derangements of the nitric oxide synthase pathway, L-arginine, and cardiovascular disease [editorial]. Circulation 1997; 95: 379-82
25. Cooke JP, Singer AH, Tsao P, et al. Anti-atherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 1992; 90: 1168-72
26. Wang B, Singer A, Tsao P, et al. Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit. J Am Coll Cardiol 1994; 23: 452-8
27. Tsao P, McEvoy LM, Drexler H, et al. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation 1994; 89: 2176-82
28. Candipan RC, Wang B, Buitrago R, et al. Regression or progression: dependency upon vascular nitric oxide. Arterioscler Thromb Vasc Biol 1996; 16: 44-50
29. Ohara Y, Petersen TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993; 91: 2546-51
30. Marui N, Offerman MK, Swerlick R, et al. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 1993; 92: 1866-72